167 related articles for article (PubMed ID: 14137402)
21. [DIABETIC RETINOPATHY AND ITS TREATMENT].
DENEUMANN PS
Arch Oftalmol B Aires; 1963 Jul; 38():207-18. PubMed ID: 14085250
[No Abstract] [Full Text] [Related]
22. FAILURE OF NON-17-ALKYLATED ANABOLIC STEROIDS TO PRODUCE ABNORMAL LIVER FUNCTION TESTS.
MARQUARDT GH; LOGAN CE; TOMHAVE WG; DOWBEN RM
J Clin Endocrinol Metab; 1964 Dec; 24():1334-6. PubMed ID: 14243179
[No Abstract] [Full Text] [Related]
23. [STUDY OF THE MECHANISM OF ACTION OF ANDROGENS ON ERYTHROPOIESIS].
NAETS JP; WITTEK M
C R Hebd Seances Acad Sci; 1964 Nov; 259():3371-4. PubMed ID: 14253249
[No Abstract] [Full Text] [Related]
24. [STUDIES ON DIABETES IN OLD AGE].
MOHNIKE G; JUTZI E
Z Gesamte Inn Med; 1963 Oct; 18():884-9. PubMed ID: 14093634
[No Abstract] [Full Text] [Related]
25. [MALNUTRITION IN THE AGED].
LOEPER J; LOEPER MJ; FORESTIER M
Prog Med (Paris); 1964 Oct; 92():643-6. PubMed ID: 14227681
[No Abstract] [Full Text] [Related]
26. [Some aspects of pathogenetic therapy of diabetic angiopathies].
Efimov AS; Skrobonskaia NA; Karabun PM; Danilova AI; Zubkova ST; Naumenko VG; MankovskiÄ BN; MelÅ„ik IM; Malik A; Tkachuk IuV
Klin Med (Mosk); 1994; 72(1):20-3. PubMed ID: 8196316
[No Abstract] [Full Text] [Related]
27. [URINARY ACID MUCOPOLYSACCHARIDE (AMP) CHANGES IN COMPLICATED DIABETES].
MINCU I; MIHALACHE N
Med Interna (Bucur); 1964 Jul; 16():803-10. PubMed ID: 14182761
[No Abstract] [Full Text] [Related]
28. [RESEARCH ON FATIGUE PREVENTION. (ACTION OF 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYLPROPIONATE)].
MAGLIO A; POTENZA P; FRANCESCONI A
Ann Med Nav (Roma); 1963; 68():797-802. PubMed ID: 14089321
[No Abstract] [Full Text] [Related]
29. [BACTERICIDAL POWER OF THE BLOOD IN PATIENTS CONVALESCING FROM TYPHOID FEVER SUBJECTED TO ANTITYPHOID VACCINATION AND TREATED WITH 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYLPROPIONATE].
LOSCHIAVO F
G Mal Infett Parassit; 1965 Feb; 17():59-62. PubMed ID: 14327118
[No Abstract] [Full Text] [Related]
30. [COMPLEMENT ACTIVITY IN ATHLETES SUBJECTED TO ANTITETANUS VACCINATION AND TREATED WITH 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYLPROPIONATE. II].
LOSCHIAVO F; GALLO D; BUCCHIARONE A
Med Sport (Roma); 1965 May; 83():332-6. PubMed ID: 14344534
[No Abstract] [Full Text] [Related]
31. [COMPLEMENT ACTIVITY IN PATIENTS CONVALESCING FROM TYPHOID FEVER SUBJECTED TO ANTITYPHOID VACCINATION AND TREATED WITH 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYL-PROPIONATE].
LOSCHIAVO F
Riforma Med; 1964 Nov; 78():1253-4. PubMed ID: 14231517
[No Abstract] [Full Text] [Related]
32. Preliminary report of a long acting anabolic agent, nandrolone decanoate.
CRAIG PE
Clin Med (Northfield); 1962 May; 69():1154-6. PubMed ID: 13881968
[No Abstract] [Full Text] [Related]
33. [GLUTAMIC-OXALACETIC TRANSAMINASE AND GLUTAMIC-PYRUVIC TRANSAMINASE IN ATHLETES SUBJECTED TO ANTITETANUS VACCINATION AND TREATED WITH 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYLPROPIONATE. I].
LOSCHIAVO F; BUCCHIARONE A; GALLO D
Med Sport (Roma); 1965 May; 83():327-31. PubMed ID: 14344533
[No Abstract] [Full Text] [Related]
34. [PATHOPHYSIOLOGY OF BLOOD PROTEIN DISORDERS AND GENESIS OF PROTEINS IN DIABETIC ANGIOPATHY. 5. THE PLACE OF THE INTERRENAL SYSTEM AND FUNCTION OF ANABOLIC STEROIDS IN THE DIABETIC-ANGIOPATHIC SERUM PROTEIN METABOLISM].
BAEHNER KJ
Z Gesamte Inn Med; 1963 Oct; 18():952-6. PubMed ID: 14093648
[No Abstract] [Full Text] [Related]
35. Treatment of diabetic retinopathy with anabolic steroids.
HOUTSMULLER AJ; van POPPEL A
Ophthalmologica; 1963; 145():185-206. PubMed ID: 13955093
[No Abstract] [Full Text] [Related]
36. STUDIES ON THE NITROGEN BALANCE IN THE HUMAN DURING LONG-TERM TREATMENT WITH DIFFERENT ANABOLIC AGENTS UNDER STRICTLY STANDARDIZED CONDITIONS.
SAARNE A; BJERSTAF L; EKMAN B
Acta Med Scand; 1965 Feb; 177():199-211. PubMed ID: 14279501
[No Abstract] [Full Text] [Related]
37. EXPERIMENTAL DIABETIC GLOMERULOSCLEROSIS. II. THE DOG.
BLOODWORTH JM
Arch Pathol; 1965 Feb; 79():113-25. PubMed ID: 14232927
[No Abstract] [Full Text] [Related]
38. [CURRENT CLINICAL PROBLEMS IN DIABETOLOGY].
AUBERTIN E
J Med Bord; 1964 Oct; 141():1481-96. PubMed ID: 14207813
[No Abstract] [Full Text] [Related]
39. [ON TREATMENT OF DYSPROTIDEMIC SYNDROMES IN GERIATRICS].
NECCHIDELLASILVA A; SEVERGNINI B
G Gerontol; 1965 Mar; 13():287-93. PubMed ID: 14335875
[No Abstract] [Full Text] [Related]
40. [SERUM MUCOPOLYSACCHARIDES AND THEIR CHANGES IN THE DEGENERATIVE COMPLICATIONS IN DIABETICS. I].
MINCU I; MIHALACHE N
Med Interna (Bucur); 1964 Jun; 16():723-8. PubMed ID: 14170455
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]